+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Regeneron Pharmaceuticals Inc - logo

Regeneron is a biotechnology company with its headquarters in New York City. Their product portfolio includes Praluent, Eylea and Arcalyst. Regeneron is a key player in research and development including drug discovery, human antibody technologies and genomics. Regeneron scientists focus on discovering new drug targets and developing effective product candidates through the proprietary VelociSuite platform of genetic technologies. In 2015 Regeneron announced a new collaboration with Sanofi to develop immuno-oncology treatments with a plan to begin clinical trials in 2016.

Fallopian Tube Cancer - Pipeline Insight, 2025 - Product Thumbnail Image

Fallopian Tube Cancer - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Allergy Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Allergy Drugs Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 183 Pages
  • Global
From
Melanoma Therapeutics: Global Markets - Product Thumbnail Image

Melanoma Therapeutics: Global Markets

  • Report
  • November 2023
  • 131 Pages
  • Global
From
Macular Edema Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type - Product Thumbnail Image

Macular Edema Therapeutics Global Market Insights 2023, Analysis and Forecast to 2028, by Manufacturers, Regions, Technology, Application, Product Type

  • Report
  • August 2023
  • 99 Pages
  • Global
From
Chylomicronemia Syndrome Market - Global Forecast 2026-2032 - Product Thumbnail Image

Chylomicronemia Syndrome Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 196 Pages
  • Global
From
Collaboration Deals in Pharmaceuticals 2021-2026 - Product Thumbnail Image

Collaboration Deals in Pharmaceuticals 2021-2026

  • Report
  • September 2026
  • 700 Pages
  • Global
From
Basal Cell Carcinoma Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Basal Cell Carcinoma Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 193 Pages
  • Global
From
Prostate Cancer Drugs Market Report 2026 - Product Thumbnail Image

Prostate Cancer Drugs Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Non-small Cell Lung Cancer Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Non-small Cell Lung Cancer Therapeutics Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 186 Pages
  • Global
From
Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update - Product Thumbnail Image

Middle East Respiratory Syndrome (MERS) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update

  • Report
  • December 2022
  • 121 Pages
  • Middle East
From
Melanoma Drug Market - Global Forecast 2026-2032 - Product Thumbnail Image

Melanoma Drug Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 190 Pages
  • Global
From
Immune Checkpoint Inhibitors for Lung Cancer Market - Global Forecast 2026-2032 - Product Thumbnail Image

Immune Checkpoint Inhibitors for Lung Cancer Market - Global Forecast 2026-2032

  • Report
  • September 2026
  • 194 Pages
  • Global
From
Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024 - Product Thumbnail Image

Wet (Neovascular / Exudative) Macular Degeneration - Global Clinical Trials Review, 2024

  • Clinical Trials
  • April 2024
  • 481 Pages
  • Global
From
Metastatic Prostate Cancer- Pipeline Insight, 2025 - Product Thumbnail Image

Metastatic Prostate Cancer- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 180 Pages
  • Global
From
Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape - Product Thumbnail Image

Chronic Obstructive Pulmonary Disease (COPD) Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape

  • Report
  • January 2023
  • 90 Pages
  • Global
From
North America Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

North America Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 111 Pages
  • North America
From
Europe Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Europe Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Europe
From
LAMEA Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

LAMEA Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Middle East, Africa
From
Asia Pacific Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030 - Product Thumbnail Image

Asia Pacific Retinal Biologics Market Size, Share & Industry Trends Analysis Report By Indication (Macular Degeneration, Diabetic Retinopathy), By Drug Class (VEGF-A Antagonist and Others), By Distribution Channel, By Country and Growth Forecast, 2023 - 2030

  • Report
  • July 2023
  • 119 Pages
  • Asia Pacific
From
Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025 - Product Thumbnail Image

Non-Opioid Drugs for Chronic Pain and Pain Management Devices Market, 2018-2025

  • Report
  • August 2018
  • 340 Pages
  • Global
From
Loading Indicator